Summary

Description (Web site quote)

HemaCare Corporation provides the customized delivery of blood products and services. HemaCare collects, processes and distributes blood products to hospitals and research related organizations. The Company operates and manages donor centers and mobile donor vehicles to collect transfusable blood products from donors, and also collects human-derived blood products which are utilized by health research related organizations. Additionally, HemaCare provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments, to patients with a variety of disorders. Blood related therapeutic services are usually provided under contract as an outside purchased service.

HemaCare has operated in Southern California since 1978. In 1998, HemaCare expanded its operations to include portions of the eastern U.S. In 2003, new management reduced the number of geographic regions served as part of a restructuring plan to return HemaCare to profitability. Since 2003, HemaCare's earnings have improved as a result of the successful implementation of management's plan. In August 2006, HemaCare acquired Florida-based Teragenix Corporation, subsequently renamed HemaCare BioScience, Inc., which sources, processes and distributes human biological specimens, manufactures quality control products and provides clinical trial management and support services.